Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C
Marija Šimin, Jesper Brok, Davor Štimac, Christian Gluud, Lise Lotte Gluud
Abstract
Marija Šimin, Jesper Brok, Davor Štimac, Christian Gluud, Lise Lotte Gluud
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C.
Key concepts: Ribavirin, Pegylated interferon, Medicine, Chronic hepatitis, Interferon, Virology, Hepatitis C, Gastroenterology